Navigation Links
Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
Date:5/14/2012

dicated for the treatment of moderate to severe active polyarticular Juvenile Idiopathic Arthritis in paediatric patients six years of age and older who have had an insufficient response to other DMARDS, including at least one TNF inhibitor. Abatacept has not been studied in children under six years old.

The most frequently reported adverse reactions (≥ 5%) among abatacept-treated patients are headache, nausea, and upper respiratory tract infections. In younger patients, side effects are similar to adults. For the full list of all side effects reported with abatacept, see the Product Information.

Abatacept should not be prescribed to persons who are hypersensitive to abatacept or any of the other ingredients. It must not be used in patients with severe and uncontrolled infections, such as sepsis or opportunistic infections. Patients who receive abatacept are given a special alert card that explains this restriction and instructs them to contact their doctor immediately if they develop an infection during a course of treatment.[2]

For a full description of abatacept, including efficacy and safety profile, please consult the Summary of Product Characteristics (SmPC): http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000701/WC500048935.pdf.

About Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a systemic, chronic, autoimmune disease characterized by inflammation in the lining of joints (or synovium), causing joint damage with chronic pain, stiffness, swelling and fatigue. RA causes limited range of motion and decreased joint function. The condition is more common in women than in men, who account for 75% of patients diagnosed with RA.

Abatacept is one treatment option indicated in adult patients with moderately to severely active RA. Abatacept ma
'/>"/>

SOURCE Bristol-Myers Squibb
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BT Signs Multi-Year, Managed Services Contract with Bristol-Myers Squibb
2. Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound
3. Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
4. GNS Healthcare Announces Collaboration With Bristol-Myers Squibb
5. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6
6. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
7. Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
8. Bristol-Myers Squibb Sued for Denying Employees Overtime Pay
9. Bend Research Announces Extension of Drug-Discovery Enablement and Development Services Agreement With Bristol-Myers Squibb
10. Isis Earns $6 Million Milestone Payment From Bristol-Myers Squibb for BMS-PCSK9Rx
11. Top Bristol-Myers Squibb Executive Joins Patton Boggs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... ROCHELLE, N.Y. , March 31, 2015 /PRNewswire-USNewswire/ ... it will be featured in the American Medical ... by ITN Productions. AMGA,s "High Performing ... on the challenges facing the nation,s healthcare system ... Medical Letter is profiled along with other leading ...
(Date:3/31/2015)... -- Accelerated orthodontic treatment will be a featured ... Annual Session, May 15-19, as seven of the ... ® . Manufactured by OrthoAccel ® Technologies, ... a FDA-cleared, Class II medical device that speeds ... percent with just 20 minutes of daily use. ...
(Date:3/31/2015)... DALLAS , March 31, 2015 ... H1 2015" therapeutic market research report of 68 ... its online business intelligence library. The ... information on the therapeutic development for Pemphigus ... therapeutics assessment by drug target, mechanism of action ...
Breaking Medicine Technology:AMGA's High Performing Health News Program Features The Medical Letter 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4
... GSK ) announced today that the U.S. Centers ... Immunization Practices (ACIP) recommended that CERVARIX® [Human papillomavirus bivalent ... girls and young women to protect against cervical pre-cancers ... 18. The ACIP specifically recommended CERVARIX for routine ...
... Accuray Incorporated (Nasdaq: ARAY ), a global ... to establish an America,s region thereby establishing regionalized management ... , The formation of this new Americas region, along ... Japan, gives each region control of revenue and profitability ...
Cached Medicine Technology:CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 2CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 3CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 4Accuray Announces Regionalized Management Strategy for Americas 2Accuray Announces Regionalized Management Strategy for Americas 3
(Date:3/31/2015)... 2015 Bon Secours New York Health ... Schervier Nursing Care Center family last week. The Sisters ... in Yonkers which is scheduled to close later this ... of the Sisters of Charity of New York, the ... to place their Sisters at Schervier Nursing Care Center ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Cosmetic Town, ... the Internet, is proudly enduring adding news to its ... and the consumers of plastic surgery and cosmetic medicine ... user-friendly pages and interconnected sections, the Cosmetic Town community ... addition to the Cosmetic Town site navigation, News and ...
(Date:3/31/2015)... 31, 2015 Karen A. Daley, Ph.D. ... Rivier University’s Commencement ceremony on May 9, ... letters in recognition of her eminent career as a ... a front-line caregiver and senior staff nurse at Brigham ... advancing to leadership roles, including President of the American ...
(Date:3/31/2015)... Indosoft, developer of the Q-Suite call center software suite, announces ... 5.x line. The industry leading contact center ACD ... for more than a decade. By announcing an end of ... fully embrace newer Asterisk features and improve performance. , Q-Suite ... more than a decade. The use of Asterisk, a free, ...
(Date:3/31/2015)... Clinovo, a leading provider of cloud-based ... the premiere voice of Northern California’s Life Science ... , BayBio brings together the collective strength ... productive life science cluster, helping companies grow, connect ... pressing challenges. , “We are thrilled to ...
Breaking Medicine News(10 mins):Health News:Bon Secours New York Health System Welcomes Retired Sisters of Charity to the Family 2Health News:Cosmetic Town is Now Transforming so Consumer can Better Navigate 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 3Health News:Indosoft Announces End of Life for Asterisk 1.4 Support in Q-Suite 5 Call Center Software 2Health News:Clinovo Joins BayBio Membership Program, The Leading Life Science Association in Northern California 2
... CryoCor, Inc. (Nasdaq:,CRYO), a medical device company focused on ... Brennan, President and Chief,Executive Officer, and Gregory J. Tibbitts, ... Group First Annual Growth Conference in,New York, NY on ... The Grand,Hyatt Hotel. A live Web cast and ...
... Sept. 17 John Brooke, General Manager of,Billian,s ... speaking at Dreamforce ,07 Global Gathering, Salesforce.com,s 5th,Annual ... week. Dreamforce is the ultimate gathering of ... base of Salesforce and AppExchance,users spanning industries, roles ...
... screening may only be modestly accurate, according to researchers from ... North Carolina. In a study that appears in the October ... the usefulness of a scale that asks patients in primary ... to 10 (worst pain). , Universal pain screening ...
... September ... 18th, NEW YORK, Sept. ... meet their millennium,commitment to halve hunger by 2015, the international development agency,ActionAid,s HungerFREE ... table" of the 62nd United Nations General Assembly,Meetings. "The UN is failing ...
... Contrary to concerns that restricting work hours for ... or the residents education, a study in the September ... Surgeons found that limiting work hours does not compromise ... study found that the new model improved overall teaching ...
... ROSEVILLE, Calif., Sept. 17 S.M.A.R.T. Association,Inc. ("SMART"), ... Council,Member" of the Smart Card Alliance, a not-for-profit, ... and,widespread application of Smart Card technology. The ... for smart card,technology, leading industry discussions on the ...
Cached Medicine News:Health News:CryoCor to Present at Maxim Group First Annual Growth Conference in New York 2Health News:Billian's HealthDATA GM Speaking on Dreamforce 07 Panel 2Health News:Rating your pain from 0 to 10 might not help your doctor 2Health News:HungerFREE Campaign Tells UN: 'Put food on the table' 2Health News:Study finds limiting work hours for surgical residents enhances training 2Health News:SMART Association Becomes 'Healthcare Council Member' of Smart Card Alliance 2
For primary and revision cases...
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
Implex cemented hip stem....
Medicine Products: